• The power of local knowledge
    on a global scale.

    No matter where your clinical development takes you, we're already there. Where are you today?

  • We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

  • There's just no denying
    good chemistry

    Explore the PRA HEALTH SCIENCES interactive experience to find out what makes us tick.

Social Media

See the latest interactions from our social media


#BioPharmaAsia Industry Awards names #PRAHealthSciences the Best CRO. This is the second time PRA has...

View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences, Inc. Reports 4th Quarter and Full Year 2014 Results and 2015 Guidance

• $323.8 million of service revenue in the fourth quarter; 8% consolidated service revenue growth compared to the fourth quarter of 2013.

• $50.6 million of Adjusted EBITDA in the...

PRA Health Sciences Announces Appointment of New Director

9 February, 2015, Raleigh, N.C. – PRA Health Sciences, Inc. (NASDAQ: PRAH) today announced the appointment of Matthew P. Young to the Board of Directors of the Company. As a member of the...

PRA Health Sciences to Report Fourth Quarter 2014 Earnings

4 February, 2015, Raleigh, N.C. – PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and year end 2014 results after the market closes on Wednesday, February 18,...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter


PRA Health Sciences (PRA) provides innovative drug development solutions across all phases and therapeutic areas. But innovation just for the sake of innovation isn’t why we do it

CAPABILITIES: Early Phase Pain Studies

In our Early Development Services (EDS) group, we have state-of-the-art Phase I facilities and equipment combined with a broad expertise in pain studies and availability of a large network of pain specialists

FACT SHEET: Rare Diseases

Clinical development involving rare diseases poses a unique set of medical, scientific, and operational challenges. PRA understands these challenges and the critical success factors necessary to develop drugs for rare disease patients


Find out what's happening next on PRA's event schedule

April 8 - April 10

The BioKorea Conference aims to provide a platform to discuss and acquire the latest knowledge on various bio topics from diverse areas such as medical care, food, agriculture, energy, chemical and the environment, thereby helping bio professionals exchange expertise and encourage collaboration

April 12 - April 14

The International Society for Pharmacoepidemiology (ISPE) is a non-profit international professional membership organization dedicated to advancing the health of the public by providing a forum for the open exchange of scientific information and for the development of policy; education; and advocacy for the field of pharmacoepidemiology, including pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness […]

April 13 - April 17

The Canadian Forum for Analytical and Bioanalytical Sciences (CFABS) is a Non-Profit Scientific Organization Formed to Promote Exchange of Knowledge and Sharing of Ideas in Analytical and Bioanalytical Sciences. The analytical & bioanalytical sciences and specifically mass spectrometry, chromatography, immunochemistry and related techniques have expanded beyond imagination in the last few years with new technologies […]

Read More >